Katja Kristan

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 4

Top Topics

Emergency Department

Induced Pluripotent Stem Cells

Chronic Rhinosinusitis

Gene Expression

Top Venues

Pharmaceutical research

The Journal of pharmacy and pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Nadica Sibinovska, Simon Žakelj, Jurij Trontelj, Katja Kristan
Applicability of RPMI 2650 and Calu-3 Cell Models for Evaluation of Nasal Formulations. Pharmaceutics 14 (2) (2022)
Nina Habjanič, Mojca Kerec Kos, Katja Kristan
Sensitivity of Different In Vitro Performance Tests and Their In Vivo Relevance for Calcipotriol/Betamethasone Ointment. Pharmaceutical research 37 (3) (2020)
Mateja Erdani Kreft, Larisa Tratnjek, Eva Lasič, Neli Hevir, Tea Lanišnik Rižner, Katja Kristan
Different Culture Conditions Affect Drug Transporter Gene Expression, Ultrastructure, and Permeability of Primary Human Nasal Epithelial Cells. Pharmaceutical research 37 (9) (2020)
Tina Jarc, Maša Novak, Neli Hevir, Tea Lanišnik Rižner, Mateja Erdani Kreft, Katja Kristan
Demonstrating suitability of the Caco-2 cell model for BCS-based biowaiver according to the recent FDA and ICH harmonised guidelines. The Journal of pharmacy and pharmacology 71 (8) (2019)